Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab pre-treatment in diabetic vitrectomy – pilot RCT
2010-024062-22Phase 4Completed
- Sponsor
- Moorfields Eye Hospital
- Start
- Feb 2011
- Modality
- Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial of ranibizumab in proliferative diabetic retinopathy (PDR) (2 arms), sponsored by Moorfields Eye Hospital. Primary endpoint: Absolute visual acuity at 12 weeks following surgery. Started Feb 2011; status: completed.
02
Drugs
ranibizumab
03
Conditions
proliferative diabetic retinopathy (PDR)
Beyond the preview
Go deeper on 2010-024062-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024062-22.